Emerging therapies transform autoimmune hepatitis treatment approaches

Autoimmune hepatitis (AIH) is a chronic, progressive liver disease caused by immune system dysregulation that targets the liver. If untreated, AIH can lead to severe complications, including cirrhosis and liver failure.

New model can explain neural and behavioral differences in autism spectrum disorder

Researchers Dr. Yuval Hart and Oded Wertheimer from the Psychology department and the Edmond and Lily Safra Center for Brain Science (ELSC) at The Hebrew

November 28, 2024

Longer treatment gave better liver outcomes for MASH patients, Akero drug study shows

Akero Therapeutics said Monday that extending treatment with its experimental drug for the liver disease known as MASH from six months to two years resulted

March 4, 2024

Single Dose of Antibiotic Cured Early Syphilis, Even in Those With HIV

BOSTON — One dose of benzathine penicillin G for the treatment of early syphilis was shown to be noninferior to a regimen of three weekly

October 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.